newsfilter
← Latest News
Business Wire·

AN2 Therapeutics Announces $40 Million Private Placement Financing

AN2 Therapeutics, Inc. (NASDAQ:ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that it has entered into a